Is levetiracetam a treatment option for dyskinetic cerebral palsy?
Mink
Jonathan W
JW
Department of Neurology, Neurobiology & Anatomy, Brain & Cognitive Sciences, and Pediatrics, University of Rochester School of Medicine & Dentistry, Rochester, NY, USA.
D000927:Anticonvulsants / Q000627:therapeutic use*; D002547:Cerebral Palsy / Q000188:drug therapy*; D002648:Child; D006801:Humans; D000077287:Levetiracetam; D010889:Piracetam / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000927:Anticonvulsants; D000077287:Levetiracetam; D010889:Piracetam